China (Mainland)
- Product Details
Keywords
- lower price
- Vildagliptin
- 274901-16-5
Quick Details
- ProName: lower price Vildagliptin（274901-16-5） ...
- CasNo: 274901-16-5
- Molecular Formula: C17H25N3O2
- Appearance: white powder
- Application: used for research
- Port: Shen Zhen or Hongkong
- ProductionCapacity: Metric Ton/Day
- Purity: 99+
- Storage: seal
- LimitNum: 1 Gram
Superiority
www.wolcase.com
Details
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1[2][3] and GIP[3] by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.[2]
Vildagliptin is a unique molecule with dual nature as it manages the glucagon levels in hypoglycemia as well as hyperglycemia.